Xiaoyan Mao

No ORCID on file · 6 papers in corpus
observational 2023
AJOG global reports ·doi:10.1016/j.xagr.2022.100098

BACKGROUND: In vitro fertilization-conceived babies, even singletons, are at a higher risk of poor birth outcomes such as low birthweight and preterm birth than naturally conceived counterparts. It remains unclear as to what extent these ad…

rct 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.00129

Object: Is it possible to use different progestins cotreatment with human menopausal gonadotrophin (hMG) in women with advanced endometriosis but normal ovulation during controlled ovarian hyperstimulation (COH) in vitro fertilization (IVF)…

observational 2019
BMC medicine ·doi:10.1186/s12916-019-1354-1

BACKGROUND: Abnormal BMI is associated with discouraging IVF outcomes in fresh autologous or oocyte donor cycles, whether or not such a relation also holds true for women undergoing frozen-thawed embryo transfer (FET) remains unknown. In ad…

2013
lab-animal 2012
Fertility and sterility ·doi:10.1016/j.fertnstert.2012.08.038

OBJECTIVE: To evaluate uterine contractility, oxytocin receptor (OTR) expression in myometrial smooth muscle cells (MSMCs) derived from uterine tissues from women with and without adenomyosis correlate OTR expression with uterine contractil…

lab-animal 2011
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719111404610

Adenomyosis is a tough disease to manage nonsurgically. Levo-tetrahydropalmatine (l-THP), a known analgesic, and andrographolide, a nuclear factor kappa B (NF-κB) inhibitor, are both active ingredients extracted from Chinese medicinal herbs…